Emmaus Life Sciences Announces Submission of EndariĀ® Marketing Authorization Application in Kuwait

Emmaus Life Sciences, Inc. (OTC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today the submission of its application for Marketing …

( read original story …)